Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 901–933 of 933
Addictions à l’héroïne, à la cocaïne, au cannabis et autres substances illicites
Blaise, M., Grégoire, M., & Valleur, M. (2025) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(25)46980-6
Perrenoud, L. O., Oikawa, K. F., Williams, A., Laranjeira, R., Fischer, B., Strang, J., & Ribeiro, M. (2021) · Figshare · doi:10.6084/m9.figshare.14478663
Eklund, L., Gunnarsson, A. B., Jansson, J.-Å., Pooremamali, P., & Eklund, M. (2021) · Figshare · doi:10.6084/m9.figshare.15087350
Gupta, A., Shebl, F. M., Tong, Y., Wagner, K., Bassett, I. V., Page, K., & Winstanley, E. L. (2022) · Figshare · doi:10.6084/m9.figshare.21376434
Gupta, A., Shebl, F. M., Tong, Y., Wagner, K., Bassett, I. V., Page, K., & Winstanley, E. L. (2022) · Figshare · doi:10.6084/m9.figshare.21376443
Saing, C. H., Prem, K., Uk, P., Chann, N., Chhoun, P., Mun, P., Tuot, S., & Yi, S. (2020) · Figshare · doi:10.6084/m9.figshare.13192309
Wojcik, S. M., Tantra, M., Stepniak, B., Man, K.-N. M., Ribbe, K., Begemann, M., Ju, A., Papiol, S., Ronnenberg, A., Gurvich, A., et al. (2013) · Figshare · doi:10.6084/m9.figshare.7193843
Gupta, A., Shebl, F. M., Tong, Y., Wagner, K., Bassett, I. V., Page, K., & Winstanley, E. L. (2022) · Figshare · doi:10.6084/m9.figshare.21376440
Gupta, A., Shebl, F. M., Tong, Y., Wagner, K., Bassett, I. V., Page, K., & Winstanley, E. L. (2022) · Figshare · doi:10.6084/m9.figshare.21376437
Addiction is a mental disorder within the mental health spectrum, and it matters
Schütz, C. G., Thiessen, K. A., Lam, A., Song, M. J., & Todesco, S. (2025) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2025.10157 · Cited by 1
Anti-saccade error rates are associated with somatic depressive symptoms in cocaine use disorder
de Dios, C., Webber, H. E., Wardle, M. C., Yoon, J. H., Patriquin, M. A., Vincent, J. N., Schmitz, J. M., & Lane, S. D. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251399579
“Depressive symptoms are common in CUD (Conway et al., 2006) and are a poor prognostic sign in CUD treatment (Palazón-Llecha et al., 2024).”
Comparative effects of antidepressants on cocaine-induced hyperthermia in rats: a preclinical study
Okada, T., Obi, S., Takano, M., Shioda, K., & Suda, S. (2026) · Neuroscience Letters · doi:10.1016/j.neulet.2026.138508
Addiction: Sex and gender evidence in alcohol, nicotine, and opioid use disorders
Marcus, M. M., Terplan, M., & Martin, C. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26712-3.00009-4
Piché, F., Morell, R., Ward, P., Rosenbaum, S., & Romain, A. J. (2026) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2025-0176
Emery, M. A., Parsegian, A., Koonse, S. A., Hebda‐Bauer, E. K., Lee, K., Luma, B. D., Chang, S. E., Becker, J., Flagel, S. B., Watson, S. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.09.717453
Reward Circuit Adaptations After Chronic Antipsychotic Treatment Confer Addiction VulnerabilityPreprint
Kruyer, A., Angelis, A., Waselenko, C., Tan, A., Xiong, S., & Amato, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.720671
Albrechet‐Souza, L., & Wills, T. A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111760
Lyman, K., Choi, J., Jutras‐Aswad, D., Foll, B. L., Klaire, S. S., & Socias, M. E. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70190
“Patients with OUD are 8–11 times more likely than the general population to have a mood or anxiety disorder [7].”
Mauro, P. M., West, B. S., Bruzelius, E., Gutkind, S., Carey, E., & Philbin, M. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00095-0
Attention-deficit/hyperactivity disorder and snuff use prior to and early in pregnancy
Andersson, A., Oskarsson, S., Kuja‐Halkola, R., Chang, Z., D'Onofrio, B. M., Larsson, H., & Tuvblad, C. (2026) · Archives of Women s Mental Health · doi:10.1007/s00737-026-01742-x
Medical Symptoms and Psychiatric Comorbidities in People with Methamphetamine Use Disorder
Marín-Navarrete, R., Sánchez-Domínguez, R., Fernández-Cáceres, C., & Saracco-Álvarez, R. A. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2026.2686086
“At the same time, depressive disorder is the second most prevalent disorder in this population (Conway & al, 2006) mainly affecting women (Hellem et al., 2015), possibly because methamphetamine use can help alleviate depression symptoms.”
Wolitzky-Taylor, K. B., & Ecker, A. H. (2026) · Behaviour Research and Therapy · doi:10.1016/j.brat.2026.105117
Ruppert, É., Rolling, J., Medde, A., Durpoix, A., & Lalanne, L. (2026) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-026-00751-4
“Depression often co-occurs with anxiety in individuals with OUD [6].”
Yang, X., Huang, Y., Liu, W., Wu, T., Liu, Z., Gao, S., Zheng, Q., Dou, Z., Zheng, J., Meng, S., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03794-y
Chavez, C. L. J., Peltier, M. R., Verplaetse, T. L., Zakiniaeiz, Y., Raval, N., & McKee, S. A. (2026) · Military Psychology · doi:10.1080/08995605.2026.2720300
Chilton, R., Sippel, L. M., van Engelen, L., & Hoff, R. A. (2026) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001881
Ohnishi, Y. H., Ohnishi, Y. N., Kawahara, Y., & Nishi, A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111951
Liu, J., Yang, L., Qiao, Q., Zhou, J., Zhang, Z., Gao, Y., & Zhang, S. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02399-4
Rosário, B. D. A., de Souza, D. V., Lemes, J. A., Sueur, L. D. P. L., Ribeiro, D. A., & Viana, M. D. B. (2026) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202620260048
Frei, A. M. (2014) · Digital Commons - University of South Florida (University of South Florida)
Smith, C. E. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/9kj1-7239
“Research suggests women may be at greater risk for comorbid substance use and psychiatric disorders than men (Conway et al., 2006).”
BackgroundMaladies mentales et addictions: En finir avec les clichés
Olié, J., Dervaux, A., & Laqueille, X. (2012) · Springer eBooks · doi:10.1007/978-2-8178-0274-9_7
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.